 Home > Biochemistry News > Biotechnology News > Regal Pharmaceuticals and Eli Lilly have reached a strategic cooperation to jointly research and develop innovative therapies for metabolic diseases

Regal Pharmaceuticals and Eli Lilly have reached a strategic cooperation to jointly research and develop innovative therapies for metabolic diseases

 Last Update: 2021-12-29
 Source: Internet
 Author: User

Tags

ranolazine drug class

clinical research intern

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Shanghai, China and Indianapolis, U.

According to the terms of the agreement, Rieger Pharmaceuticals granted Eli Lilly the United States a license for the intellectual property rights of Rieger Pharmaceuticals, and Eli Lilly can choose to extend the license

"In just over three years, Rieger Pharmaceuticals has developed into a world-class biomedical innovation company with an independent AI-assisted new drug research and development platform CARD (Computer Accelerated Rational Discovery)

"The cooperation with Rieger Pharmaceuticals has further expanded Eli Lilly to provide more treatments for patients with metabolic diseases around the world," said Dr.

Regal Pharmaceuticals will receive a total of 50 million US dollars in advance, including part of the equity investment

About Ruige Pharmaceutical

Regal Pharmaceuticals is a biomedical high-tech company in the clinical stage

About Eli Lilly

Eli Lilly is a world-leading pharmaceutical company dedicated to improving human health through innovation

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.